Clinical Trials Browser

Melanoma, Sarcoma, Neoplasm, Residual

Adenomatous Polyposis Coli, Colorectal Neoplasms

Mesothelioma, Malignant, Esophageal Neoplasms, Lung Neoplasms, Sarcoma, Thymoma

Lung Neoplasms, Melanoma, Neoplasm Metastasis, Neoplasms, Sarcoma

Esophageal Neoplasms, Lung Neoplasms, Mesothelioma, Thymoma

Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Small Cell Lung Carcinoma

Melanoma, Neoplasm Metastasis, Sarcoma

Melanoma, Neoplasm Metastasis, Neoplasms, Germ Cell and Embryonal, Sarcoma

Colonic Neoplasms, Gastrointestinal Neoplasms, Liver Neoplasms, Neoplasms

Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma

Breast Neoplasms

Smoking, Tobacco Use Disorder

Carcinoma, Non-Small-Cell Lung

Breast Neoplasms

Head and Neck Neoplasms

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Carcinoma, Basal Cell

Colorectal Neoplasms

Carcinoma, Non-Small-Cell Lung

Colonic Neoplasms, Rectal Neoplasms

Carcinoma, Basal Cell

Urinary Bladder Neoplasms

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Colorectal Neoplasms

Temporomandibular Joint Disorders

Clinical Trials

Adjuvant Tumor Lysate Vaccine and Iscomatrix With or Without Metronomic Oral Cyclophosphamide and Celecoxib in Patients With Malignancies Involving Lungs, Esophagus, Pleura, or Mediastinum

Celecoxib With or Without Eflornithine in Preventing Colorectal Cancer in Patients With Familial Adenomatous Polyposis

Pilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, and Malignant Pleural Mesotheliomas

Tumor Cell Vaccine for Patients Undergoing Surgery for Sarcomas, Melanomas, Germ Cell Tumors, or Malignancies That Have Metastasized to the Lungs, Pleura, or Mediastinum

Tumor Cell Vaccines With ISCOMATRIX Adjuvant and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers and Malignant Pleural Mesotheliomas

Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion With or Without Concurrent Celecoxib in Subjects With Pulmonary and Pleural Malignancies

Tumor Cell Vaccines and ISCOMATRIX With Chemotherapy After Tumor Removal

Adjuvant Oral Decitabine and Tetrahydrouridine With or Without Celecoxib in People Undergoing Pulmonary Metastasectomy

Vaccine Therapy and Radiation to Liver Metastasis in Patients With CEA-Positive Solid Tumors

Celecoxib in Preventing Multiple Myeloma in Patients With Monoclonal Gammopathy or Smoldering Myeloma

Celecoxib in Treating Postmenopausal Women Who Are Undergoing Surgery for Invasive Breast Cancer

Zileuton With or Without Celecoxib As Chemopreventive Agents in Smokers

Celecoxib and Erlotinib in Treating Former Smokers With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Celecoxib and Trastuzumab in Treating Women With Metastatic Breast Cancer

Vaccine Therapy and Celecoxib in Treating Patients With Metastatic Nasopharyngeal Cancer

Celecoxib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Celecoxib in Preventing Basal Cell Carcinoma in Patients With Basal Cell Nevus Syndrome

Celecoxib in Preventing Cancer in Patients With Rectal Polyps or Colorectal Neoplasia

Erlotinib and Celecoxib in Treating Patients With Stage IIIB or Stage IV Recurrent Non-Small Cell Lung Cancer

Celecoxib to Prevent Colorectal Cancer in Patients Who Have Undergone Surgery to Remove Polyps

Celecoxib in Preventing Skin Cancer

Celecoxib in Treating Patients With Bladder Cancer

Celecoxib in Treating Patients With Head and Neck Cancer That Can Be Removed By Surgery

Celecoxib, Leucovorin, Fluorouracil, and Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer

Celecoxib or Observation After Radiation Therapy and Chemotherapy in Treating Patients With Stage II or Stage III Non-Small Cell Lung Cancer

Phase I-II Multiple-Dose Safety and Efficacy Study of a Selective Inhibitor of Cyclooxygenase - 2 (SC-58635) in Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Patients and Carriers

Study of Etanercept and Celecoxib to Treat Temporomandibular Disorders (Painful Joint Conditions)